This Chinese memory chip maker has global potential and is poised to outperform
Source: CNBC

CLSA initiated coverage of CXMT with an outperform rating and an 84.70-yuan price target, more than 60% above Friday’s close, citing rising memory prices and opportunities to sell abroad; it projected global bit-shipment share of 14% next year, versus 9% last year. Bernstein also rates the stock outperform with a 70-yuan target, while BNP Paribas is neutral at 48.70 yuan and expects September-quarter revenue to rise 22% quarter on quarter. Analysts flagged U.S. production-tool restrictions and valuation concerns; CXMT is expected to report earnings Oct. 31.
Analysis
The key issue is whether CXMT can turn domestic scale into qualified, exportable supply—not whether its bit shipments rise. Shipment share is not revenue share or proof of comparable yields, product mix, or profitability. Any overseas adoption is also likely segmented: products sold outside the U.S. may provide a route to demand, while U.S.-bound and sensitive applications remain exposed to customer and policy constraints. A restriction on production tools could limit capacity or technology progression even if near-term demand is strong.
If CXMT supplies more DRAM into a tight market, it may initially add needed capacity; over 6–18 months, successful qualification could instead weaken pricing power for established suppliers including Samsung, SK Hynix, and Micron. The risk is greater if capacity arrives as current tightness eases. The TSMC valuation comparison is not a sound read-through to TSM: foundry economics and memory-cycle exposure differ, and the article provides no basis for a TSM earnings impact.
The near-term catalyst is CXMT’s October 31 results. Quarter-on-quarter revenue growth, if reported, would not by itself validate overseas penetration or sustainable margins. Consensus may be underweight geopolitical adoption barriers, while bullish targets may overstate the significance of shipment-share gains. The thesis weakens if results or guidance disappoint, tool access tightens, or customer qualification remains limited; it strengthens with verifiable non-China customer wins and evidence of profitable output.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.35
Key Decisions for Investors
- Do not trade TSM on this report: CXMT’s competitive position is not evidence of a direct change in TSM’s foundry demand or economics.
- Avoid chasing CXMT on analyst price targets alone. Before taking exposure, verify October 31 results, product mix and margins, capacity utilization, and independently confirmed non-China customer qualification.
- Treat the near-term memory-supply squeeze as potentially supportive for incumbent suppliers, but monitor Samsung, SK Hynix, and Micron for pricing and guidance: sustained CXMT share gains could become a medium-term pricing headwind if supply growth outpaces demand.
- Set an alert for evidence of tool-access restrictions or export-control changes, and for overseas customer adoption beyond Chinese OEM products; either could materially change the addressable market and the competitive timeline.
More News
- What to Expect in Markets This Week: Big Bank Reports Fire Up Earnings Season; Inflation, Retail Sales Figures Land
- 3 Things to Watch When Taiwan Semiconductor (TSMC) Reports Earnings on Oct. 15
- The Week Ahead: JPMorgan, Goldman Sachs Earnings and CPI Test Stock Market Strength
- TSMC Reports Oct. 15. It's the Best Early Read on Nvidia's Next Quarter.
- Meet the Only AI Stock I'd Buy Over Nvidia in October
- VOO Doesn't Hold SpaceX, Taiwan Semiconductor, Samsung Electronics, SK Hynix, or ASML. Meet the Vanguard ETF That Does.
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- AI Financial Research Benchmarks: What the Scores Mean
- State of M&A and Private Markets, June 2026: A $4.9 Trillion Rebound, Underwritten on Money That Never Got Cheaper